A Single Oral Dose of Thalidomide Enhances the Capacity of Lymphocytes to Secrete Gamma Interferon in Healthy Humans

Thalidomide is increasingly being used as adjuvant therapy for patients with mycobacterial and human immunodeficiency virus (HIV) infections. The T-helper (Th)1 cytokine–Th2 cytokine balance critically determines the outcomes of these diseases. To obtain insight into the effect of thalidomide on the...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Verbon, Annelies, Juffermans, Nicole P., Speelman, Peter, van Deventer, Sander J. H., ten Berge, Ineke J. M., Guchelaar, Henk-Jan, van der Poll, Tom
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2000
Soggetti:
Biologic Response Modifiers
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC90059/
https://ncbi.nlm.nih.gov/pubmed/10952569
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi